Aciclovir | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Aciclovir
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aciclovir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

82 API Suppliers, 32 USDMF, 19 CEP/COS, 8 JDMF, 11 EU WC, 37 KDMF, 27 NDC API, 48 Listed Suppliers, $ API Reference Price

82 API Suppliers
32 USDMF
19 CEP/COS
8 JDMF
11 EU WC
37 KDMF
27 NDC API
48 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

383 FDF Dossiers, 97 FDA Orange Book, 122 Europe, 17 Canada, 18 Australia, 29 South Africa, 100 Listed Dossiers

383 FDF Dossiers
97 FDA Orange Book
122 Europe
17 Canada
18 Australia
29 South Africa
100 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 200MG/5ML, TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 5%;1%

CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUSPENSION;ORAL - 200MG/5ML
TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CREAM;TOPICAL - 5%;1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 10 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 36 BASF, 3 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 22 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 3 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

66 Fillers, Diluents & Binders, 38 Disintegrants & Superdisintegrants, 35 Thickeners and Stabilizers, 29 Direct Compression, 27 Granulation, 25 Topical, 23 Coating Systems & Additives, 22 Solubilizers, 18 Film Formers & Plasticizers, 16 Controlled & Modified Release, 16 Lubricants & Glidants, 14 Parenteral, 12 Taste Masking, 11 Chewable & Orodispersible Aids, 11 Co-Processed Excipients, 8 Empty Capsules, 7 Emulsifying Agents, 5 Rheology Modifiers, 3 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin, 1 API Stability Enhancers

66 Fillers, Diluents & Binders
38 Disintegrants & Superdisintegrants
35 Thickeners and Stabilizers
29 Direct Compression
27 Granulation
25 Topical
23 Coating Systems & Additives
22 Solubilizers
18 Film Formers & Plasticizers
16 Controlled & Modified Release
16 Lubricants & Glidants
14 Parenteral
12 Taste Masking
11 Chewable & Orodispersible Aids
11 Co-Processed Excipients
8 Empty Capsules
7 Emulsifying Agents
5 Rheology Modifiers
3 Coloring Agents
2 Surfactant & Foaming Agents
1 Soft Gelatin
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 113 Finished Drug Prices

2 US Medicaid Prescriptions
113 Finished Drug Prices

MARKET PLACE

41 APIs, 23 FDF Dossiers

41 APIs
23 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 2 US Exclusivities, 3 Health Canada Patents

3 US Patents
2 US Exclusivities
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 12 Others

1 USP
12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 204 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3LNHC

filter Patent Number Reset all filters

3 All

01 18592434

02 18747896

03 18791127

filter API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 12027-03-23

02 12027-06-03

03 12030-06-16

Product Main Page

01

LNHC

PharmScience R&D

Not Confirmed

LNHC

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-03

US Patent Number : 8747896

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203791

Patent Use Code : U-1460

Delist Requested :

Patent Use Description : TREATMENT OF HERPES LA...

Patent Expiration Date : 2027-06-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

LNHC

PharmScience R&D

Not Confirmed

LNHC

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-16

US Patent Number : 8592434

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203791

Patent Use Code : U-1460

Delist Requested :

Patent Use Description : TREATMENT OF HERPES LA...

Patent Expiration Date : 2030-06-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

LNHC

PharmScience R&D

Not Confirmed

LNHC

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-03-23

US Patent Number : 8791127

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 203791

Patent Use Code : U-1460

Delist Requested :

Patent Use Description : TREATMENT OF HERPES LA...

Patent Expiration Date : 2027-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!